Delivery of ultraviolet-inactivated 35S-herpesvirus across an osmotically modified blood-brain barrier

Edward Neuwelt, M. A. Pagel, R. D. Dix

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The present studies were undertaken to detemine if viral particles can be delivered across the rat blood-brain barrier (BBB). Osmotic BBB modification with intracarotid mannitol (25%) was immediately followed by bolus intracarotid administration of 0.5 ml purified, ultraviolet-inactivated, herpes simplex virus type 1 endogenously labeled with 35S-labeled methionine (2.0 x 106 cpm, approximately 5 x 108 plaque-forming units/ml). After 60 minutes, intravascular virus was cleared by saline perfusion and the animals were sacrificed. A marked increase (fourfold, p ≤ 0.02) in radioactivity was observed in the ipsilateral brain hemisphere when compared to control animals without barrier modification. Administration of intravenous virus immediately after BBB modification displayed no difference in delivery when compared to intracarotid saline-infused controls (without BBB modification) suggesting the importance of a first-pass phenomenon. There were no significant differences in serum concentrations among intracarotid or intravenous groups. These preliminary studies suggest the possibility of delivering viral particles across the BBB with osmotic disruption, which may permit delivery of genetic material in replication-defective viral vectors in the feline model of G(M2)-gangliosidosis.

Original languageEnglish (US)
Pages (from-to)475-479
Number of pages5
JournalJournal of Neurosurgery
Volume74
Issue number3
StatePublished - 1991

Fingerprint

Herpesviridae
Blood-Brain Barrier
Virion
GM2 Gangliosidosis
Viruses
Felidae
Human Herpesvirus 1
Mannitol
Intravenous Administration
Methionine
Radioactivity
Perfusion
Brain
Serum
Genes

Keywords

  • Blood-brain barrier
  • Herpesvirus
  • Replication-defective vectors

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Delivery of ultraviolet-inactivated 35S-herpesvirus across an osmotically modified blood-brain barrier. / Neuwelt, Edward; Pagel, M. A.; Dix, R. D.

In: Journal of Neurosurgery, Vol. 74, No. 3, 1991, p. 475-479.

Research output: Contribution to journalArticle

@article{b7935b68aabb45d2a3374e38d1c593b8,
title = "Delivery of ultraviolet-inactivated 35S-herpesvirus across an osmotically modified blood-brain barrier",
abstract = "The present studies were undertaken to detemine if viral particles can be delivered across the rat blood-brain barrier (BBB). Osmotic BBB modification with intracarotid mannitol (25{\%}) was immediately followed by bolus intracarotid administration of 0.5 ml purified, ultraviolet-inactivated, herpes simplex virus type 1 endogenously labeled with 35S-labeled methionine (2.0 x 106 cpm, approximately 5 x 108 plaque-forming units/ml). After 60 minutes, intravascular virus was cleared by saline perfusion and the animals were sacrificed. A marked increase (fourfold, p ≤ 0.02) in radioactivity was observed in the ipsilateral brain hemisphere when compared to control animals without barrier modification. Administration of intravenous virus immediately after BBB modification displayed no difference in delivery when compared to intracarotid saline-infused controls (without BBB modification) suggesting the importance of a first-pass phenomenon. There were no significant differences in serum concentrations among intracarotid or intravenous groups. These preliminary studies suggest the possibility of delivering viral particles across the BBB with osmotic disruption, which may permit delivery of genetic material in replication-defective viral vectors in the feline model of G(M2)-gangliosidosis.",
keywords = "Blood-brain barrier, Herpesvirus, Replication-defective vectors",
author = "Edward Neuwelt and Pagel, {M. A.} and Dix, {R. D.}",
year = "1991",
language = "English (US)",
volume = "74",
pages = "475--479",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "3",

}

TY - JOUR

T1 - Delivery of ultraviolet-inactivated 35S-herpesvirus across an osmotically modified blood-brain barrier

AU - Neuwelt, Edward

AU - Pagel, M. A.

AU - Dix, R. D.

PY - 1991

Y1 - 1991

N2 - The present studies were undertaken to detemine if viral particles can be delivered across the rat blood-brain barrier (BBB). Osmotic BBB modification with intracarotid mannitol (25%) was immediately followed by bolus intracarotid administration of 0.5 ml purified, ultraviolet-inactivated, herpes simplex virus type 1 endogenously labeled with 35S-labeled methionine (2.0 x 106 cpm, approximately 5 x 108 plaque-forming units/ml). After 60 minutes, intravascular virus was cleared by saline perfusion and the animals were sacrificed. A marked increase (fourfold, p ≤ 0.02) in radioactivity was observed in the ipsilateral brain hemisphere when compared to control animals without barrier modification. Administration of intravenous virus immediately after BBB modification displayed no difference in delivery when compared to intracarotid saline-infused controls (without BBB modification) suggesting the importance of a first-pass phenomenon. There were no significant differences in serum concentrations among intracarotid or intravenous groups. These preliminary studies suggest the possibility of delivering viral particles across the BBB with osmotic disruption, which may permit delivery of genetic material in replication-defective viral vectors in the feline model of G(M2)-gangliosidosis.

AB - The present studies were undertaken to detemine if viral particles can be delivered across the rat blood-brain barrier (BBB). Osmotic BBB modification with intracarotid mannitol (25%) was immediately followed by bolus intracarotid administration of 0.5 ml purified, ultraviolet-inactivated, herpes simplex virus type 1 endogenously labeled with 35S-labeled methionine (2.0 x 106 cpm, approximately 5 x 108 plaque-forming units/ml). After 60 minutes, intravascular virus was cleared by saline perfusion and the animals were sacrificed. A marked increase (fourfold, p ≤ 0.02) in radioactivity was observed in the ipsilateral brain hemisphere when compared to control animals without barrier modification. Administration of intravenous virus immediately after BBB modification displayed no difference in delivery when compared to intracarotid saline-infused controls (without BBB modification) suggesting the importance of a first-pass phenomenon. There were no significant differences in serum concentrations among intracarotid or intravenous groups. These preliminary studies suggest the possibility of delivering viral particles across the BBB with osmotic disruption, which may permit delivery of genetic material in replication-defective viral vectors in the feline model of G(M2)-gangliosidosis.

KW - Blood-brain barrier

KW - Herpesvirus

KW - Replication-defective vectors

UR - http://www.scopus.com/inward/record.url?scp=0025974559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025974559&partnerID=8YFLogxK

M3 - Article

VL - 74

SP - 475

EP - 479

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 3

ER -